PubMed:24403068 / 1242-1500 JSONTXT

{"project":"PubMed_ArguminSci","denotations":[{"id":"T9","span":{"begin":0,"end":258},"obj":"DRI_Approach"}],"text":"Co-precipitation of serglycin from conditioned medium of MM cells using a CD44-Fc chimera suggests that CD44 is the cell surface-binding partner for serglycin, which therefore may serve as a major ligand for CD44 at various stages during myeloma progression."}

{"project":"sentences","denotations":[{"id":"T9","span":{"begin":0,"end":258},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Co-precipitation of serglycin from conditioned medium of MM cells using a CD44-Fc chimera suggests that CD44 is the cell surface-binding partner for serglycin, which therefore may serve as a major ligand for CD44 at various stages during myeloma progression."}

{"project":"DisGeNET","denotations":[{"id":"T20","span":{"begin":208,"end":212},"obj":"gene:960"},{"id":"T21","span":{"begin":238,"end":245},"obj":"disease:C0026764"},{"id":"T22","span":{"begin":104,"end":108},"obj":"gene:960"},{"id":"T23","span":{"begin":238,"end":245},"obj":"disease:C0026764"},{"id":"T24","span":{"begin":149,"end":158},"obj":"gene:5552"},{"id":"T25","span":{"begin":238,"end":245},"obj":"disease:C0026764"},{"id":"T26","span":{"begin":20,"end":29},"obj":"gene:5552"},{"id":"T27","span":{"begin":57,"end":59},"obj":"disease:C0026764"},{"id":"T28","span":{"begin":20,"end":29},"obj":"gene:5552"},{"id":"T29","span":{"begin":238,"end":245},"obj":"disease:C0026764"},{"id":"T30","span":{"begin":74,"end":78},"obj":"gene:960"},{"id":"T31","span":{"begin":238,"end":245},"obj":"disease:C0026764"}],"relations":[{"id":"R11","pred":"associated_with","subj":"T20","obj":"T21"},{"id":"R12","pred":"associated_with","subj":"T22","obj":"T23"},{"id":"R13","pred":"associated_with","subj":"T24","obj":"T25"},{"id":"R14","pred":"associated_with","subj":"T26","obj":"T27"},{"id":"R15","pred":"associated_with","subj":"T28","obj":"T29"},{"id":"R16","pred":"associated_with","subj":"T30","obj":"T31"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Co-precipitation of serglycin from conditioned medium of MM cells using a CD44-Fc chimera suggests that CD44 is the cell surface-binding partner for serglycin, which therefore may serve as a major ligand for CD44 at various stages during myeloma progression."}

{"project":"DisGeNET5_gene_disease","denotations":[{"id":"24403068-8#74#78#gene960","span":{"begin":74,"end":78},"obj":"gene960"},{"id":"24403068-8#104#108#gene960","span":{"begin":104,"end":108},"obj":"gene960"},{"id":"24403068-8#208#212#gene960","span":{"begin":208,"end":212},"obj":"gene960"},{"id":"24403068-8#238#245#diseaseC0026764","span":{"begin":238,"end":245},"obj":"diseaseC0026764"}],"relations":[{"id":"74#78#gene960238#245#diseaseC0026764","pred":"associated_with","subj":"24403068-8#74#78#gene960","obj":"24403068-8#238#245#diseaseC0026764"},{"id":"104#108#gene960238#245#diseaseC0026764","pred":"associated_with","subj":"24403068-8#104#108#gene960","obj":"24403068-8#238#245#diseaseC0026764"},{"id":"208#212#gene960238#245#diseaseC0026764","pred":"associated_with","subj":"24403068-8#208#212#gene960","obj":"24403068-8#238#245#diseaseC0026764"}],"text":"Co-precipitation of serglycin from conditioned medium of MM cells using a CD44-Fc chimera suggests that CD44 is the cell surface-binding partner for serglycin, which therefore may serve as a major ligand for CD44 at various stages during myeloma progression."}

{"project":"mondo_disease","denotations":[{"id":"T13","span":{"begin":57,"end":59},"obj":"Disease"},{"id":"T14","span":{"begin":238,"end":245},"obj":"Disease"}],"attributes":[{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0009693"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0005170"},{"id":"A15","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0009693"}],"text":"Co-precipitation of serglycin from conditioned medium of MM cells using a CD44-Fc chimera suggests that CD44 is the cell surface-binding partner for serglycin, which therefore may serve as a major ligand for CD44 at various stages during myeloma progression."}

{"project":"GlyCosmos15-HP","denotations":[{"id":"T12","span":{"begin":57,"end":59},"obj":"Phenotype"}],"attributes":[{"id":"A12","pred":"hp_id","subj":"T12","obj":"HP:0006775"}],"text":"Co-precipitation of serglycin from conditioned medium of MM cells using a CD44-Fc chimera suggests that CD44 is the cell surface-binding partner for serglycin, which therefore may serve as a major ligand for CD44 at various stages during myeloma progression."}

{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T13","span":{"begin":57,"end":59},"obj":"Disease"},{"id":"T14","span":{"begin":238,"end":245},"obj":"Disease"}],"attributes":[{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0009693"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0005170"},{"id":"A15","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0009693"}],"text":"Co-precipitation of serglycin from conditioned medium of MM cells using a CD44-Fc chimera suggests that CD44 is the cell surface-binding partner for serglycin, which therefore may serve as a major ligand for CD44 at various stages during myeloma progression."}

{"project":"sentences","denotations":[{"id":"T9","span":{"begin":0,"end":258},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Co-precipitation of serglycin from conditioned medium of MM cells using a CD44-Fc chimera suggests that CD44 is the cell surface-binding partner for serglycin, which therefore may serve as a major ligand for CD44 at various stages during myeloma progression."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T8","span":{"begin":0,"end":258},"obj":"Sentence"}],"text":"Co-precipitation of serglycin from conditioned medium of MM cells using a CD44-Fc chimera suggests that CD44 is the cell surface-binding partner for serglycin, which therefore may serve as a major ligand for CD44 at various stages during myeloma progression."}

{"project":"HP-phenotype","denotations":[{"id":"T12","span":{"begin":57,"end":59},"obj":"Phenotype"}],"attributes":[{"id":"A12","pred":"hp_id","subj":"T12","obj":"HP:0006775"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Co-precipitation of serglycin from conditioned medium of MM cells using a CD44-Fc chimera suggests that CD44 is the cell surface-binding partner for serglycin, which therefore may serve as a major ligand for CD44 at various stages during myeloma progression."}